# EleVation carE: a Randomized Controlled Trial on the Prevention of Acute Mountain Sickness With Suxiao Jiuxin Pill

> **NCT06531161** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 168 (estimated)

## Conditions studied

- Acute Mountain Sickness

## Interventions

- **DRUG:** Suxiao Jiuxin Pill
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06531161
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-08
- **Primary completion:** 2024-09
- **Final completion:** 2025-09
- **Target enrollment:** 168 (ESTIMATED)
- **Last updated:** 2024-08-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06531161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06531161, "EleVation carE: a Randomized Controlled Trial on the Prevention of Acute Mountain Sickness With Suxiao Jiuxin Pill". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06531161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*